½ÃÀ庸°í¼­
»óǰÄÚµå
1550075

¼¼°èÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¿¹Ãø(2024-2032³â)

Molecular Transport Medium Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 336 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Persistence Market Research´Â ºÐÀÚ ¿î¼Û ¹èÁö ¼¼°è ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ º¸°í¼­¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ º¸°í¼­´Â ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ ¹× °úÁ¦¸¦ Æ÷ÇÔÇÑ Áß¿äÇÑ ½ÃÀå ¿ªÇÐÀ» öÀúÈ÷ Æò°¡ÇÏ°í ½ÃÀå ±¸Á¶¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

  • ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ±Ô¸ð(2024E) : 11¾ï 4,700¸¸ ´Þ·¯
  • ½ÃÀå ¿¹ÃøÄ¡(2032F) :12¾ï 7,200¸¸ ´Þ·¯
  • ¼¼°è ½ÃÀå ¼ºÀå·ü(CAGR 2024³âºÎÅÍ 2032³â±îÁö) : 1.3%

ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå-º¸°í ¹üÀ§:

ºÐÀÚ ¿î¼Û ¹èÁö´Â ƯÈ÷ °¨¿°ÀÇ Áø´Ü °Ë»ç¸¦ À§ÇÑ ÀÓ»ó Ç¥º»ÀÇ º¸Á¸°ú ¼ö¼Û¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ ¹èÁö´Â Á¤È®ÇÑ ºÐÀÚ ºÐ¼®À» À§ÇØ RNA¿Í DNA »ùÇÃÀÇ ¹«°á¼ºÀ» À¯ÁöÇϵµ·Ï Ưº°È÷ ¼³°èµÇ¾úÀ¸¸ç ´Ù¾çÇÑ Áúº´À» Áø´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀåÀº º´¿ø, Áø´Ü ½ÇÇè½Ç, Á¶»ç ±â°ü, »ý¸í °øÇÐ ±â¾÷¿¡ ¼­ºñ½º¸¦ Á¦°øÇÏ¸ç ¹ÙÀÌ·¯½º, ¹ÚÅ׸®¾Æ ¹× ¹ü¿ë ¿î¼Û ¹èÁö¸¦ Æ÷ÇÔÇÑ ´Ù¾çÇÑ ¼ö¼Û ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº Áø´Ü °Ë»ç ¼ö¿ä Áõ°¡, °¨¿°Áõ À¯Çà Áõ°¡, ºÐÀÚÁø´Ü ±â¼úÀÇ Áøº¸¿¡ ÀÇÇÑ ½Ã·á º¸Á¸ ¹× ¼ö¼Û È¿À²ÀÇ Çâ»óÀÔ´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:

¼¼°èÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀåÀº Á¤È®ÇÑ Áø´Ü °Ë»ç, ƯÈ÷ COVID-19, ÀÎÇ÷翣ÀÚ ¹× ±âŸ ½ÅÈï º´¿øÃ¼¿Í °°Àº ¹ÙÀÌ·¯½º °¨¿°¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡¿Í °°Àº ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù. Àü¿°º´ÀÇ ¼¼°è À¯Çà°ú ±×¿¡ µû¸¥ ºÐÀÚÁø´ÜÀ» À§ÇÑ ½Å·ÚÇÒ ¼ö ÀÖ´Â ¿î¼Û ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå È®´ë°¡ ´õ¿í °­È­µÇ°í ÀÖ½À´Ï´Ù. ¹ÙÀÌ·¯½º ºÒȰ¼ºÈ­ ¿î¼Û ¹èÁö °³¹ß ¹× ½Ã·á º¸Á¸ ±â¼ú °­È­¿Í °°Àº ±â¼úÀû Áøº¸´Â Áø´Ü °Ë»çÀÇ Á¤È®¼ºÀ» Çâ»ó½ÃŰ°í ¿À¿° À§ÇèÀ» ÁÙÀÌ°í ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡, À¯ÀüüÇÐ¿Í ¸ÂÃãÇü ÀÇ·á¿¡¼­ÀÇ ¿¬±¸°³¹ß Ȱµ¿¿¡ ´ëÇÑ ÁÖ¸ñ Áõ°¡´Â ÷´Ü ºÐÀڰ˻翡 ƯȭµÈ ¿î¼Û ¹èÁö¸¦ Á¦°øÇÏ´Â ½ÃÀåÂü°¡ÀÚ¿¡°Ô »õ·Î¿î ±âȸ¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ:

À¯¸ÁÇÑ ¼ºÀå Àü¸Á¿¡µµ ºÒ±¸Çϰí, ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀåÀº ±ÔÁ¤ Áؼö, °ø±Þ¸Á È¥¶õ, ºñ¿ë Á¦¾à°ú °ü·ÃµÈ ¹®Á¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ¿î¼Û ¸ÅüÀÇ Á¦Á¶, ¿î¼Û ¹× »ç¿ëÀ» ±ÔÁ¤ÇÏ´Â ¾ö°ÝÇÑ ±ÔÁ¦´Â Á¦Á¶¾÷ü¿¡ ÄÄÇöóÀ̾𽺿¡ ºÎ´ãÀ» ÁÖ¾î ½ÃÀå ÁøÀÔ À庮 ¹× ¿î¿µ ºñ¿ë¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. °Ô´Ù°¡, ƯÈ÷ ¼¼°è º¸°Ç º¸°Ç ±ä±Þ »óȲ¿¡¼­´Â °ø±Þ¸Á ¹®Á¦°¡ Áß¿äÇÑ ¿î¼Û ¸Åü ºÎÁ·À¸·Î À̾îÁ® Áø´Ü °Ë»ç ´É·Â¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. Ư¼ö ºÐÀÚ ¿î¼Û ¹èÁöÀÇ ºñ¿ëÀÌ ³ô°í ÀÌ¿ë °¡´ÉÇÑ Áö¿ªÀÌ Á¦ÇѵǾî ÀÖ´Â °ÍÀº ƯÈ÷ ÀÇ·á ¿¹»ê¿¡ Á¦¾àÀÌ ÀÖ´Â ½ÅÈï °æÁ¦±¹¿¡¼­ ½ÃÀå ħÅõÀÇ °úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦ ¹× ¹°·ù À庮À» ÇØ°áÇϱâ À§Çؼ­´Â ¾ÈÀüÇϰí È¿°úÀûÀÎ ¿î¼Û ¼Ö·ç¼ÇÀÇ Áö¼ÓÀûÀÎ °ø±ÞÀ» º¸ÀåÇϱâ À§ÇØ ¾÷°è ÀÌÇØ °ü°èÀÚ¿Í Á¤Ã¥ ÀÔ¾ÈÀÚÀÇ Çù·ÂÀÌ ÇÊ¿äÇÕ´Ï´Ù.

½ÃÀå ±âȸ:

ºÐÀÚ ¿î¼Û ¹èÁö½ÃÀåÀº ±â¼ú Çõ½Å, Á¶»çȰµ¿ È®´ë, ÇコÄɾî Á¦°ø ¸ðµ¨ÀÇ ÁøÈ­¸¦ ¿øµ¿·ÂÀ¸·Î ÇÏ´Â Å« ¼ºÀå ±âȸ¸¦ Á¦½ÃÇϰí ÀÖ½À´Ï´Ù. ÀÚµ¿È­µÈ ½Ã·á Ãë±Þ°ú ¿î¼Û ±â¼úÀÇ ÅëÇÕÀº ½ÇÇè½ÇÀÇ È¿À²¼ºÀ» ³ôÀ̰í Áø´Ü ¿öÅ©Ç÷ο쿡¼­ ÀÎÀ§ÀûÀÎ ½Ç¼ö¸¦ ÁÙ¿©ÁÝ´Ï´Ù. °Ô´Ù°¡, ¸ÂÃãÇü ÀÇ·á ¹× À¯ÀüüÇÐ ¿¬±¸¿¡ À־ÀÇ ºÐÀÚ ¿î¼Û ¹èÁöÀÇ ÀÀ¿ë È®´ë°¡ ½ÃÀåÀÇ ¹üÀ§¸¦ ³ÐÇô ±â¼ú Çõ½ÅÀ» ÀÚ±ØÇϰí ÀÖ½À´Ï´Ù. Àü·«Àû ÆÄÆ®³Ê½Ê, R&D ÅõÀÚ, ºñ¿ë È¿À²ÀûÀÎ ¿î¼Û ¼Ö·ç¼ÇÀÇ µµÀÔÀº »õ·Î¿î ±âȸ¸¦ Ȱ¿ëÇÏ°í ¿ªµ¿ÀûÀÎ ºÐÀÚ ¿î¼Û ·£µå½ºÄÉÀÌÇÁ¿¡¼­ ½ÃÀåÀÇ ¸®´õ½ÊÀ» À¯ÁöÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

  • ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀåÀÇ ¼¼°è ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
  • ¾î¶² ¿î¼Û ¸ÅüÀÇ À¯Çü°ú ¿ëµµ°¡ ´Ù¾çÇÑ ÇコÄɾî ȯ°æ¿¡¼­ÀÇ Ã¤¿ëÀ» ÃËÁøÇϰí Àִ°¡?
  • ±â¼ú Áøº¸´Â ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå °æÀï ±¸µµ¸¦ ¾î¶»°Ô ¹Ù²Ù°í Àִ°¡?
  • ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå¿¡ ±â¿©ÇÏ´Â ÁÖ¿ä ±â¾÷Àº ´©±¸ÀÌ¸ç ½ÃÀå °ü·Ã¼ºÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» äÅÃÇϰí Àִ°¡?
  • ¼¼°èÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå¿¡¼­ÀÇ »õ·Î¿î µ¿Çâ°ú Àü¸ÁÀº?

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

  • ½ÃÀå ¹üÀ§/ºÐ·ù
  • ½ÃÀåÀÇ Á¤ÀÇ/¹üÀ§/Á¦ÇÑ
  • Æ÷ÇÔ°ú Á¦¿Ü

Á¦3Àå ÁÖ¿ä ½ÃÀå µ¿Çâ

  • ½ÃÀå¿¡ ¿µÇâÀ» ÁÖ´Â ÁÖ¿ä µ¿Çâ
  • Á¦Ç° Çõ½Å/°³¹ß µ¿Çâ

Á¦4Àå ÁÖ¿ä ³»¿ë

  • Á¦Ç° ä¿ë ºÐ¼®
  • Á¦Á¶¾÷ü°¡ ä¿ëÇÑ ÁÖ¿ä Àü·«
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • PESTLE ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå ½ÃÀå ¹è°æ

  • °Å½Ã°æÁ¦ ¿äÀÎ
  • ¿¹Ãø ¿äÀÎ- °ü·Ã¼º°ú ¿µÇâ
  • ½ÃÀå ¿ªÇÐ

Á¦6Àå COVID-19 À§±â ºÐ¼®

  • 2024³â ½ÃÀå ½Ã³ª¸®¿À
  • COVID-19¿Í ¿µÇ⠺м®
    • Á¦Ç° À¯Çü
    • ¿ëµµº°
    • »ùÇú°
    • ÃÖÁ¾ »ç¿ëÀÚº°
    • Áö¿ªº°

Á¦7Àå ¼¼°è ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå - °¡°Ý ºÐ¼®

  • ¼¼°è Æò±Õ °¡°Ý ºÐ¼® º¥Ä¡¸¶Å©
  • °¡°ÝÀÇ »óÁ¤

Á¦8Àå ¼¼°èÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ¼ö¿ä(°¡Ä¡ ¶Ç´Â ±Ô¸ð, 10¾ï ´Þ·¯) ºÐ¼®

  • ½ÃÀå ¸ÅÃâ(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
  • ½ÃÀå ¸ÅÃâ(10¾ï ´Þ·¯) ¿¹Ãø, 2024-2032³â
    • Àü³â´ëºñ ¼ºÀå µ¿Ç⠺м®
    • Àý´ë ¼öÀÍ ±âȸ

Á¦9Àå Á¦Ç° À¯Çüº°: ¼¼°èÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®

  • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
  • ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
  • ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, 2024-2032³â
    • Ȱ¼ºÈ­ ¿î¼Û ¹èÁö
    • ºÒȰ¼ºÈ­ ¿î¼Û ¹èÁö

Á¦10Àå ¿ëµµº° : ¼¼°èÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®

  • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
  • ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
  • ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, 2024-2032³â
    • ¹ÙÀÌ·¯½º
      • COVID-19
      • Áßµ¿ È£Èí±â ÁõÈıº(MERS)
      • ÀÎÇ÷翣ÀÚ
      • COVID-19
      • Àΰ£ ¸é¿ª°áÇÌ ¹ÙÀÌ·¯½º(HIV)
      • ¸®³ë¹ÙÀÌ·¯½º
      • ¾Æµ¥³ë¹ÙÀÌ·¯½º
      • È£Èí±â ÇÕÆ÷ü ¹ÙÀÌ·¯½º(RSV)
    • ¹ÚÅ׸®¾Æ
      • Æ÷µµ»ó±¸±Õ¼º Æó·Å
      • ÀÎÇ÷翣ÀÚ±Õ
      • źÀú±Õ
      • ±âŸ
    • ºñÁ¤Çü ¼¼±Õ
      • ¸¶ÀÌÄÚÇö󽺸¶
      • Q¿­
      • ±âŸ
    • °áÇÙ±Õ ¹× Áø±Õ °¨¿°

Á¦11Àå »ùÇú°: ¼¼°èÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®

  • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
  • ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
  • ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, 2024-2032³â
    • ÄÚ ¼¼Ã´°ú ¸éºÀ
    • °´´ã
    • Ÿ¾×
    • ´ë¹ø
    • ¼Òº¯
    • ÇÇ
    • Ƽ½´
    • ±âŸ

Á¦12Àå ÃÖÁ¾ »ç¿ëÀÚº°: ¼¼°èÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®

  • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
  • ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
  • ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, 2024-2032³â
    • Áø´Ü ½ÇÇè½Ç
    • ¹Ì»ý¹°ÇÐ ¿¬±¸¼Ò
    • º´¿ø ¹× Ŭ¸®´Ð
    • ±âŸ

Á¦13Àå Áö¿ªº°: ¼¼°èÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®

  • ¼Ò°³
  • ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
  • ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, 2024-2032³â
    • ºÏ¹Ì
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • À¯·´
    • ³²¾Æ½Ã¾Æ
    • µ¿¾Æ½Ã¾Æ
    • ¿À¼¼¾Æ´Ï¾Æ
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«)

Á¦14Àå ºÏ¹Ì ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®

Á¦15Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®

Á¦16Àå À¯·´ÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®

Á¦17Àå ³²¾Æ½Ã¾Æ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®

Á¦18Àå µ¿¾Æ½Ã¾ÆÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®

Á¦19Àå ¿À¼¼¾Æ´Ï¾ÆÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®

Á¦20Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®

Á¦21Àå ½ÃÀå ±¸Á¶ ºÐ¼®

  • ±â¾÷ Tierº° ½ÃÀå ºÐ¼®
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁß
  • ½ÃÀåÇöÀçºÐ¼®

Á¦22Àå °æÀï ºÐ¼®

  • °æÀï ´ë½Ãº¸µå
  • °æÀï º¥Ä¡¸¶Å·
  • °æÀïÀÇ »ó¼¼
    • Thermo Fisher Scientific
    • Becton Dickinson and Company
    • Cardinal Health
    • Quidel Corporation
    • Medical Wire &Equipment(MWE)
    • COPAN Diagnostics Inc.(COPAN Group)
    • Titan Biotech Ltd.
    • Alpha Teknova, Inc.(formerly named Teknova)
    • Bio-Genex Laboratories Inc.
    • EKF Diagnostics
    • Trinity Biotech
    • Alpha-Tec Systems, Inc.
    • Charm Sciences, Inc.
    • Azer Scientific
    • bioBoaVista
    • AccuGene
    • KSL Diagnostics
    • Puritan Medical Products
    • Amazing Biotech(Shanghai) Co., Ltd.

Á¦23Àå »ç¿ëµÈ ÀüÁ¦Á¶°Ç°ú ¾à¾î

Á¦24Àå Á¶»ç ¹æ¹ý

JHS 24.10.04

Persistence Market Research has recently released a comprehensive report on the worldwide market for molecular transport medium. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Molecular Transport Medium Market Size (2024E): USD 1.147 Billion
  • Projected Market Value (2032F): USD 1.272 Billion
  • Global Market Growth Rate (CAGR 2024 to 2032): 1.3%

Molecular Transport Medium Market - Report Scope:

Molecular transport medium plays a crucial role in preserving and transporting clinical specimens for diagnostic testing, particularly for infectious diseases. This medium is specifically designed to maintain the integrity of RNA and DNA samples for accurate molecular analysis, aiding in the diagnosis of various conditions. The molecular transport medium market serves hospitals, diagnostic laboratories, research institutions, and biotechnology companies, offering a range of transport solutions, including viral, bacterial, and general-purpose transport mediums. Market growth is driven by the increasing demand for diagnostic testing, rising prevalence of infectious diseases, and advancements in molecular diagnostics technology, enhancing specimen preservation and transportation efficiency.

Market Growth Drivers:

The global molecular transport medium market is propelled by several key factors, including the growing need for accurate diagnostic testing, particularly for viral infections like COVID-19, influenza, and other emerging pathogens. The rising prevalence of infectious diseases globally and the subsequent demand for reliable transport solutions for molecular diagnostics further drive market expansion. Technological advancements, such as the development of viral inactivation transport mediums and enhanced specimen preservation technologies, offer improved accuracy in diagnostic testing and reduce the risk of contamination, fostering market growth. Moreover, the increasing focus on research and development activities in genomics and personalized medicine creates new opportunities for market players to provide specialized transport mediums for advanced molecular testing.

Market Restraints:

Despite promising growth prospects, the molecular transport medium market faces challenges related to regulatory compliance, supply chain disruptions, and cost constraints. Stringent regulations governing the manufacturing, transportation, and use of transport mediums impose compliance burdens on manufacturers, affecting market entry barriers and operational costs. Furthermore, supply chain issues, particularly during global health emergencies, can lead to shortages of critical transport mediums, impacting diagnostic testing capacities. The high cost of specialized molecular transport mediums and limited availability in certain regions pose challenges for market penetration, particularly in emerging economies with constrained healthcare budgets. Addressing these regulatory and logistical barriers requires collaboration between industry stakeholders and policymakers to ensure the continuous supply of safe and effective transport solutions.

Market Opportunities:

The molecular transport medium market presents significant growth opportunities driven by technological innovations, expanding research activities, and evolving healthcare delivery models. The integration of automated specimen handling and transport technologies enhances laboratory efficiency and reduces human error in diagnostic workflows. Furthermore, the growing application of molecular transport mediums in personalized medicine and genomics research broadens the market scope and stimulates innovation. Strategic partnerships, investment in research and development, and the introduction of cost-effective transport solutions are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic molecular transport landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the molecular transport medium market globally?
  • Which transport medium types and applications are driving adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the molecular transport medium market?
  • Who are the key players contributing to the molecular transport medium market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global molecular transport medium market?

Competitive Intelligence and Business Strategy:

Leading players in the global molecular transport medium market, including Thermo Fisher Scientific, Becton, Dickinson and Company, and COPAN Diagnostics Inc., focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced transport mediums, including viral inactivation solutions and enhanced stabilization formulas, catering to diverse diagnostic needs and research requirements. Collaborations with healthcare providers, diagnostic laboratories, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and customer education fosters market growth and enhances specimen integrity in the rapidly evolving molecular diagnostics landscape.

Key Companies Profiled:

  • Thermo Fisher Scientific
  • Becton, Dickinson and Company
  • COPAN Diagnostics Inc.
  • Puritan Medical Products
  • BioMed Diagnostics
  • Hardy Diagnostics
  • Longhorn Vaccines & Diagnostics
  • Titan Biotech Ltd.
  • Starplex Scientific
  • HiMedia Laboratories

Key Segments Covered in Molecular Transport Medium Industry Research

Molecular Transport Medium Market by Product Type:

  • Active Transport Medium
  • Inactivated Transport Medium

Molecular Transport Medium Market by Application:

  • Virus
  • Bacteria
  • Atypical Bacteria
  • Mycobacterial and Fungal Infection

Molecular Transport Medium Market by Sample:

  • Nasal Washes and Swabs
  • Sputum
  • Saliva
  • Faecal & Stool
  • Urine
  • Blood
  • Tissues

Molecular Transport Medium Market by End User:

  • Diagnostic Laboratories
  • Microbiology Laboratories
  • Hospitals & Clinics

Molecular Transport Medium Market by Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply-Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Inclusions

  • 4.1. Product Adoption Analysis
  • 4.2. Key Strategies Adopted by Manufacturers
  • 4.3. Regulatory Scenario
  • 4.4. PESTLE Analysis
  • 4.5. Porter's Analysis
  • 4.6. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Outlook
    • 5.1.2. Global Healthcare Spending Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. COVID-19 Pandemic
    • 5.2.2. Product Launches
    • 5.2.3. GDP Growth
    • 5.2.4. Increasing Prevalence of Infectious Diseases
    • 5.2.5. R&D Expenditure by Key Players
    • 5.2.6. Product Adoption Rate
    • 5.2.7. Regulatory Scenario
    • 5.2.8. Strategic Acquisitions and Mergers among Key Players
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. 2024 Market Scenario
  • 6.2. COVID-19 and Impact Analysis
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By Sample
    • 6.2.4. By End User
    • 6.2.5. By Region

7. Global Molecular Transport Medium Market- Pricing Analysis

  • 7.1. Global Average Pricing Analysis Benchmark
  • 7.2. Pricing Assumption

8. Global Molecular Transport Medium Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2032

  • 8.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 8.2. Current and Future Market Value (US$ Bn) Projections, 2024-2032
    • 8.2.1. Y-o-Y Growth Trend Analysis
    • 8.2.2. Absolute $ Opportunity Analysis

9. Global Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032, By Product Type

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis by Product Type, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Product Type, 2024-2032
    • 9.3.1. Active Transport Medium
    • 9.3.2. Inactivated Transport Medium

10. Global Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032, By Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis by Application, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Application, 2024-2032
    • 10.3.1. Virus
      • 10.3.1.1. COVID-19
      • 10.3.1.2. Middle East respiratory syndrome (MERS)
      • 10.3.1.3. Influenza
      • 10.3.1.4. COVID-19
      • 10.3.1.5. Human Immunodeficiency Virus (HIV)
      • 10.3.1.6. Rhinovirus
      • 10.3.1.7. Adenovirus
      • 10.3.1.8. Respiratory Syncytial Virus (RSV)
    • 10.3.2. Bacteria
      • 10.3.2.1. Staphylococcus pneumonia
      • 10.3.2.2. Haemophilus influenzae
      • 10.3.2.3. Anthrax
      • 10.3.2.4. Others
    • 10.3.3. Atypical Bacteria
      • 10.3.3.1. Mycoplasma
      • 10.3.3.2. Q-Fever
      • 10.3.3.3. Others
    • 10.3.4. Mycobacterial and Fungal Infection

11. Global Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032, By Sample

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis by Sample, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Sample, 2024-2032
    • 11.3.1. Nasal Washes and Swabs
    • 11.3.2. Sputum
    • 11.3.3. Saliva
    • 11.3.4. Faecal & Stool
    • 11.3.5. Urine
    • 11.3.6. Blood
    • 11.3.7. Tissues
    • 11.3.8. Others

12. Global Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032, By End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Bn) Analysis by End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by End User, 2024-2032
    • 12.3.1. Diagnostic Laboratories
    • 12.3.2. Microbiology Laboratories
    • 12.3.3. Hospitals & Clinics
    • 12.3.4. Others

13. Global Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Analysis by Region, 2019-2023
  • 13.3. Current Market Size (US$ Bn) Analysis and Forecast by Region, 2024-2032
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. South Asia
    • 13.3.5. East Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)

14. North America Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
  • 14.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product Type
    • 14.3.3. By Application
    • 14.3.4. By Sample
    • 14.3.5. By End User
  • 14.4. Market Trends
  • 14.5. Key Market Participants - Intensity Mapping
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. U.S. Molecular Transport Medium Market
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.1.2.1. By Product Type
        • 14.7.1.2.2. By Application
        • 14.7.1.2.3. By Sample
        • 14.7.1.2.4. By End User
    • 14.7.2. Canada Molecular Transport Medium Market
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.2.2.1. By Product Type
        • 14.7.2.2.2. By Application
        • 14.7.2.2.3. By Sample
        • 14.7.2.2.4. By End User

15. Latin America Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
  • 15.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
    • 15.3.1. By Country
      • 15.3.1.1. Brazil
      • 15.3.1.2. Mexico
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product Type
    • 15.3.3. By Application
    • 15.3.4. By Sample
    • 15.3.5. By End User
  • 15.4. Market Trends
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. Brazil Molecular Transport Medium Market
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.1.2.1. By Product Type
        • 15.7.1.2.2. By Application
        • 15.7.1.2.3. By Sample
        • 15.7.1.2.4. By End User
    • 15.7.2. Argentina Molecular Transport Medium Market
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.2.2.1. By Product Type
        • 15.7.2.2.2. By Application
        • 15.7.2.2.3. By Sample
        • 15.7.2.2.4. By End User
    • 15.7.3. Mexico Molecular Transport Medium Market
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.3.2.1. By Product Type
        • 15.7.3.2.2. By Application
        • 15.7.3.2.3. By Sample
        • 15.7.3.2.4. By End User

16. Europe Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
  • 16.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. BENELUX
      • 16.3.1.7. Nordic Countries
      • 16.3.1.8. Russia
      • 16.3.1.9. Rest of Europe
    • 16.3.2. By Product Type
    • 16.3.3. By Application
    • 16.3.4. By Sample
    • 16.3.5. By End User
  • 16.4. Market Trends
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. Germany Molecular Transport Medium Market
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.1.2.1. By Product Type
        • 16.7.1.2.2. By Application
        • 16.7.1.2.3. By Sample
        • 16.7.1.2.4. By End User
    • 16.7.2. France Molecular Transport Medium Market
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.2.2.1. By Product Type
        • 16.7.2.2.2. By Application
        • 16.7.2.2.3. By Sample
        • 16.7.2.2.4. By End User
    • 16.7.3. Italy Molecular Transport Medium Market
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.3.2.1. By Product Type
        • 16.7.3.2.2. By Sample
        • 16.7.3.2.3. By End User
    • 16.7.4. Spain Molecular Transport Medium Market
      • 16.7.4.1. Introduction
      • 16.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.4.2.1. By Product Type
        • 16.7.4.2.2. By Application
        • 16.7.4.2.3. By Sample
        • 16.7.4.2.4. By End User
    • 16.7.5. U.K. Molecular Transport Medium Market
      • 16.7.5.1. Introduction
      • 16.7.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.5.2.1. By Product Type
        • 16.7.5.2.2. By Application
        • 16.7.5.2.3. By Sample
        • 16.7.5.2.4. By End User
    • 16.7.6. BENELUX Union Molecular Transport Medium Market
      • 16.7.6.1. Introduction
      • 16.7.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.6.2.1. By Product Type
        • 16.7.6.2.2. By Application
        • 16.7.6.2.3. By Sample
        • 16.7.6.2.4. By End User
    • 16.7.7. Nordic Countries Molecular Transport Medium Market
      • 16.7.7.1. Introduction
      • 16.7.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.7.2.1. By Product Type
        • 16.7.7.2.2. By Application
        • 16.7.7.2.3. By Sample
        • 16.7.7.2.4. By End User
    • 16.7.8. Russia Molecular Transport Medium Market
      • 16.7.8.1. Introduction
      • 16.7.8.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.8.2.1. By Product Type
        • 16.7.8.2.2. By Application
        • 16.7.8.2.3. By Sample
        • 16.7.8.2.4. By End User

17. South Asia Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
  • 17.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Thailand
      • 17.3.1.3. Indonesia
      • 17.3.1.4. Malaysia
      • 17.3.1.5. Vietnam
      • 17.3.1.6. Philippines
      • 17.3.1.7. Rest of South Asia
    • 17.3.2. By Product Type
    • 17.3.3. By Application
    • 17.3.4. By Sample
    • 17.3.5. By End User
  • 17.4. Market Trends
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. India Molecular Transport Medium Market
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.1.2.1. By Product Type
        • 17.7.1.2.2. By Application
        • 17.7.1.2.3. By Sample
        • 17.7.1.2.4. By End User
    • 17.7.2. Indonesia Molecular Transport Medium Market
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.2.2.1. By Product Type
        • 17.7.2.2.2. By Application
        • 17.7.2.2.3. By Sample
        • 17.7.2.2.4. By End User
    • 17.7.3. Vietnam Molecular Transport Medium Market
      • 17.7.3.1. Introduction
      • 17.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.3.2.1. By Product Type
        • 17.7.3.2.2. By Application
        • 17.7.3.2.3. By Sample
        • 17.7.3.2.4. By End User
    • 17.7.4. Philippines Molecular Transport Medium Market
      • 17.7.4.1. Introduction
      • 17.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.4.2.1. By Product Type
        • 17.7.4.2.2. By Application
        • 17.7.4.2.3. By Sample
        • 17.7.4.2.4. By End User
    • 17.7.5. Malaysia Molecular Transport Medium Market
      • 17.7.5.1. Introduction
      • 17.7.5.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.5.2.1. By Product Type
        • 17.7.5.2.2. By Application
        • 17.7.5.2.3. By Sample
        • 17.7.5.2.4. By End User
    • 17.7.6. Thailand Molecular Transport Medium Market
      • 17.7.6.1. Introduction
      • 17.7.6.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.6.2.1. By Product Type
        • 17.7.6.2.2. By Application
        • 17.7.6.2.3. By Sample
        • 17.7.6.2.4. By End User

18. East Asia Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
  • 18.3. Market Size (US$ Bn) Forecast by Market Taxonomy, 2024-2032
    • 18.3.1. By Country
      • 18.3.1.1. China
      • 18.3.1.2. Japan
      • 18.3.1.3. South Korea
    • 18.3.2. By Product Type
    • 18.3.3. By Application
    • 18.3.4. By Sample
    • 18.3.5. By End User
  • 18.4. Market Trends
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. China Molecular Transport Medium Market
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.1.2.1. By Product Type
        • 18.7.1.2.2. By Application
        • 18.7.1.2.3. By Sample
        • 18.7.1.2.4. By End User
    • 18.7.2. Japan Molecular Transport Medium Market
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.2.2.1. By Product Type
        • 18.7.2.2.2. By Application
        • 18.7.2.2.3. By Sample
        • 18.7.2.2.4. By End User
    • 18.7.3. South Korea Molecular Transport Medium Market
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.3.2.1. By Product Type
        • 18.7.3.2.2. By Application
        • 18.7.3.2.3. By Sample
        • 18.7.3.2.4. By End User

19. Oceania Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
  • 19.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product Type
    • 19.3.3. By Application
    • 19.3.4. By Sample
    • 19.3.5. By End User
  • 19.4. Market Trends
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Country Level Analysis & Forecast
    • 19.7.1. Australia Molecular Transport Medium Market
      • 19.7.1.1. Introduction
      • 19.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.7.1.2.1. By Product Type
        • 19.7.1.2.2. By Application
        • 19.7.1.2.3. By Sample
        • 19.7.1.2.4. By End User
    • 19.7.2. New Zealand Molecular Transport Medium Market
      • 19.7.2.1. Introduction
      • 19.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.7.2.2.1. By Product Type
        • 19.7.2.2.2. By Application
        • 19.7.2.2.3. By Sample
        • 19.7.2.2.4. By End User

20. Middle East and Africa (MEA) Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
  • 20.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkey
      • 20.3.1.3. Israel
      • 20.3.1.4. North Africa
      • 20.3.1.5. South Africa
      • 20.3.1.6. Rest of Middle East and Africa
    • 20.3.2. By Product Type
    • 20.3.3. By Application
    • 20.3.4. By Sample
    • 20.3.5. By End User
  • 20.4. Market Trends
  • 20.5. Key Market Participants - Intensity Mapping
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Country Level Analysis & Forecast
    • 20.7.1. GCC Countries Molecular Transport Medium Market
      • 20.7.1.1. Introduction
      • 20.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.1.2.1. By Product Type
        • 20.7.1.2.2. By Application
        • 20.7.1.2.3. By Sample
        • 20.7.1.2.4. By End User
    • 20.7.2. Israel Molecular Transport Medium Market
      • 20.7.2.1. Introduction
      • 20.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.2.2.1. By Product Type
        • 20.7.2.2.2. By Application
        • 20.7.2.2.3. By Sample
        • 20.7.2.2.4. By End User
    • 20.7.3. Turkey Molecular Transport Medium Market
      • 20.7.3.1. Introduction
      • 20.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.3.2.1. By Product Type
        • 20.7.3.2.2. By Application
        • 20.7.3.2.3. By Sample
        • 20.7.3.2.4. By End User
    • 20.7.4. South Africa Molecular Transport Medium Market
      • 20.7.4.1. Introduction
      • 20.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.4.2.1. By Product Type
        • 20.7.4.2.2. By Application
        • 20.7.4.2.3. By Sample
        • 20.7.4.2.4. By End User
    • 20.7.5. North Africa Molecular Transport Medium Market
      • 20.7.5.1. Introduction
      • 20.7.5.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.5.2.1. By Product Type
        • 20.7.5.2.2. By Application
        • 20.7.5.2.3. By Sample
        • 20.7.5.2.4. By End User

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Concentration
  • 21.4. Market Presence Analysis
    • 21.4.1. Regional footprint of Players
    • 21.4.2. Product footprint by Players
    • 21.4.3. Channel Foot Print by Players

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive
    • 22.3.1. Thermo Fisher Scientific
      • 22.3.1.1. Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.1.4. Sales Footprint
      • 22.3.1.5. Strategy Overview
      • 22.3.1.6. Key Developments
      • 22.3.1.7. SWOT Analysis
    • 22.3.2. Becton Dickinson and Company
      • 22.3.2.1. Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.2.4. Sales Footprint
      • 22.3.2.5. Strategy Overview
      • 22.3.2.6. Key Developments
      • 22.3.2.7. SWOT Analysis
    • 22.3.3. Cardinal Health
      • 22.3.3.1. Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.3.4. Sales Footprint
      • 22.3.3.5. Strategy Overview
      • 22.3.3.6. Key Developments
      • 22.3.3.7. SWOT Analysis
    • 22.3.4. Quidel Corporation
      • 22.3.4.1. Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.4.4. Sales Footprint
      • 22.3.4.5. Strategy Overview
      • 22.3.4.6. Key Developments
      • 22.3.4.7. SWOT Analysis
    • 22.3.5. Medical Wire & Equipment (MWE)
      • 22.3.5.1. Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.5.4. Sales Footprint
      • 22.3.5.5. Strategy Overview
      • 22.3.5.6. Key Developments
      • 22.3.5.7. SWOT Analysis
    • 22.3.6. COPAN Diagnostics Inc. [COPAN Group]
      • 22.3.6.1. Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.6.4. Sales Footprint
      • 22.3.6.5. Strategy Overview
      • 22.3.6.6. Key Developments
      • 22.3.6.7. SWOT Analysis
    • 22.3.7. Titan Biotech Ltd.
      • 22.3.7.1. Overview
      • 22.3.7.2. Product Portfolio
      • 22.3.7.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.7.4. Sales Footprint
      • 22.3.7.5. Strategy Overview
      • 22.3.7.6. Key Developments
      • 22.3.7.7. SWOT Analysis
    • 22.3.8. Alpha Teknova, Inc. [formerly named Teknova]
      • 22.3.8.1. Overview
      • 22.3.8.2. Product Portfolio
      • 22.3.8.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.8.4. Sales Footprint
      • 22.3.8.5. Strategy Overview
      • 22.3.8.6. Key Developments
      • 22.3.8.7. SWOT Analysis
    • 22.3.9. Bio-Genex Laboratories Inc.
      • 22.3.9.1. Overview
      • 22.3.9.2. Product Portfolio
      • 22.3.9.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.9.4. Sales Footprint
      • 22.3.9.5. Strategy Overview
      • 22.3.9.6. Key Developments
      • 22.3.9.7. SWOT Analysis
    • 22.3.10. EKF Diagnostics
      • 22.3.10.1. Overview
      • 22.3.10.2. Product Portfolio
      • 22.3.10.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.10.4. Sales Footprint
      • 22.3.10.5. Strategy Overview
      • 22.3.10.6. Key Developments
      • 22.3.10.7. SWOT Analysis
    • 22.3.11. Trinity Biotech
      • 22.3.11.1. Overview
      • 22.3.11.2. Product Portfolio
      • 22.3.11.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.11.4. Sales Footprint
      • 22.3.11.5. Strategy Overview
      • 22.3.11.6. Key Developments
      • 22.3.11.7. SWOT Analysis
    • 22.3.12. Alpha-Tec Systems, Inc.
      • 22.3.12.1. Overview
      • 22.3.12.2. Product Portfolio
      • 22.3.12.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.12.4. Sales Footprint
      • 22.3.12.5. Strategy Overview
      • 22.3.12.6. Key Developments
      • 22.3.12.7. SWOT Analysis
    • 22.3.13. Charm Sciences, Inc.
      • 22.3.13.1. Overview
      • 22.3.13.2. Product Portfolio
      • 22.3.13.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.13.4. Sales Footprint
      • 22.3.13.5. Strategy Overview
      • 22.3.13.6. Key Developments
      • 22.3.13.7. SWOT Analysis
    • 22.3.14. Azer Scientific
      • 22.3.14.1. Overview
      • 22.3.14.2. Product Portfolio
      • 22.3.14.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.14.4. Sales Footprint
      • 22.3.14.5. Strategy Overview
      • 22.3.14.6. Key Developments
      • 22.3.14.7. SWOT Analysis
    • 22.3.15. bioBoaVista
      • 22.3.15.1. Overview
      • 22.3.15.2. Product Portfolio
      • 22.3.15.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.15.4. Sales Footprint
      • 22.3.15.5. Strategy Overview
      • 22.3.15.6. Key Developments
      • 22.3.15.7. SWOT Analysis
    • 22.3.16. AccuGene
      • 22.3.16.1. Overview
      • 22.3.16.2. Product Portfolio
      • 22.3.16.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.16.4. Sales Footprint
      • 22.3.16.5. Strategy Overview
      • 22.3.16.6. Key Developments
      • 22.3.16.7. SWOT Analysis
    • 22.3.17. KSL Diagnostics
      • 22.3.17.1. Overview
      • 22.3.17.2. Product Portfolio
      • 22.3.17.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.17.4. Sales Footprint
      • 22.3.17.5. Strategy Overview
      • 22.3.17.6. Key Developments
      • 22.3.17.7. SWOT Analysis
    • 22.3.18. Puritan Medical Products
      • 22.3.18.1. Overview
      • 22.3.18.2. Product Portfolio
      • 22.3.18.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.18.4. Sales Footprint
      • 22.3.18.5. Strategy Overview
      • 22.3.18.6. Key Developments
      • 22.3.18.7. SWOT Analysis
    • 22.3.19. Amazing Biotech (Shanghai) Co., Ltd.
      • 22.3.19.1. Overview
      • 22.3.19.2. Product Portfolio
      • 22.3.19.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.19.4. Sales Footprint
      • 22.3.19.5. Strategy Overview
      • 22.3.19.6. Key Developments
      • 22.3.19.7. SWOT Analysis

23. Assumptions and Acronyms Used

24. Research Methodology

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦